Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
IDH2 抑制剂 enasidenib 治疗急性髓系白血病的克隆异质性
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-018-0115-6
Lynn Quek, Muriel D David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan Shih, Bilyana Stoilova, Cyril Quivoron, Maël Heiblig, Christophe Willekens, Véronique Saada, Samar Alsafadi, M S Vijayabaskar, Andy Peniket, Oliver A Bernard, Sam Agresta, Katharine Yen, Kyle MacBeth, Eytan Stein, Ge